A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease.
作者信息
Reddy Bharathi V, Chapman Arlene B
机构信息
Department of Medicine, Section of Nephrology University of Chicago, Chicago, Illinois.
出版信息
Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1695-1698. doi: 10.2215/CJN.02830317. Epub 2017 Aug 7.
Abstract
摘要
相似文献
1
A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease.一名患有导致常染色体显性多囊肾病的新型基因突变的患者。
Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1695-1698. doi: 10.2215/CJN.02830317. Epub 2017 Aug 7.
2
Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.患有常染色体显性多囊肾病并寻求辅助生殖的中国患者中PKD基因的新突变。
BMC Med Genet. 2018 Oct 17;19(1):186. doi: 10.1186/s12881-018-0693-7.
3
KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.KHA-CARI常染色体显性多囊肾病诊断与管理指南建议
Nephrology (Carlton). 2016 Aug;21(8):705-16. doi: 10.1111/nep.12658.
4
Identification of novel mutations and risk assessment of Han Chinese patients with autosomal dominant polycystic kidney disease.中国汉族常染色体显性遗传性多囊肾病患者的新突变鉴定及风险评估
Nephrology (Carlton). 2019 May;24(5):504-510. doi: 10.1111/nep.13270.
5
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.单等位基因 IFT140 致病性变异是常染色体显性多囊肾病谱表型的一个重要原因。
Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9.
6
Simultaneous adult polycystic kidney disease and Alport syndrome.成人多囊肾病与奥尔波特综合征并存。
Nephrology (Carlton). 2016 Aug;21(8):722-3. doi: 10.1111/nep.12661.
7
Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.常染色体显性多囊肾病的分子途径与治疗方法
Physiology (Bethesda). 2015 May;30(3):195-207. doi: 10.1152/physiol.00032.2014.
8
Multiple cysts in the liver autosomal dominant polycystic liver disease.肝脏中的多个囊肿见于常染色体显性多囊肝病。
Neth J Med. 2006 Jun;64(6):199-201.
9
PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病相关的蛛网膜囊肿。
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105943. doi: 10.1016/j.jstrokecerebrovasdis.2021.105943. Epub 2021 Jun 25.
10
Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.编码葡萄糖苷酶IIα亚基的GANAB基因突变导致常染色体显性多囊肾和肝病。
Am J Hum Genet. 2016 Jun 2;98(6):1193-1207. doi: 10.1016/j.ajhg.2016.05.004.
引用本文的文献
1
Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects.常染色体显性遗传性多囊肾病与吡格列酮治疗：全面综述，重点介绍分子发病机制和药理学方面。
Mol Med. 2020 Dec 11;26(1):128. doi: 10.1186/s10020-020-00246-3.
2
Haploinsufficiency Does Not Cause Polycystic Kidney Disease or Polycystic Liver Disease in Mice.杂合性不足不会导致小鼠多囊肾病或多囊肝病。
Biomed Res Int. 2020 May 19;2020:7469428. doi: 10.1155/2020/7469428. eCollection 2020.
3
Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease.《加拿大关于评估常染色体显性多囊肾病疾病进展风险及药物治疗的最新专家共识》
Can J Kidney Health Dis. 2018 Oct 12;5:2054358118801589. doi: 10.1177/2054358118801589. eCollection 2018.
4
Clinical Features of 167 Inpatients with Autosomal Dominant Polycystic Kidney Disease at a Single Center in China.中国单中心 167 例常染色体显性遗传性多囊肾病住院患者的临床特征。
Med Sci Monit. 2018 Sep 16;24:6498-6505. doi: 10.12659/MSM.910127.
Zotero 插件